Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-06-25Clinical Trial Update: the Study of STABLE_SR for Persistent Atrial Fibrillation [NA]
This clinical trial update concerns the study of STABLE_SR for persistent atrial fibrillation; the status and phase details are not provided…
-
CLINICAL_TRIALS withdrawal · 2013-06-21Clinical Trial Update: Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders: The ACTUAL Study [Phase 4]
A Phase 4 clinical trial evaluating atrial fibrillation after catheter versus thoracoscopic ablation using patient-activated implantable loo…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: RF Ablation of Atrial Fibrillation [Phase 1]
This document updates on a Phase 1 clinical trial evaluating radiofrequency ablation for atrial fibrillation; the study is completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol [Phase 4]
A Phase 4 clinical trial evaluating pharmacogenetic-guided dosing of acenocoumarol for venous thromboembolism and atrial fibrillation has co…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon [Phase 4]
Phase 4 study evaluating pharmacogenetics of phenprocoumon in preventing thrombotic events in venous thromboembolism and atrial fibrillation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-06-17Clinical Trial Update: Oral Anticoagulation and Self-management [NA]
This clinical trial update discusses oral anticoagulation and patient self-management for atrial fibrillation with embolism; the current tri…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation [Phase 4]
This Phase 4 trial update evaluates the pharmacokinetics and optimal timing of initiating dronedarone after long-term amiodarone in patients…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: The Study of Warfarin Maintenance Dose in Chinese Patients
This document provides an update on a clinical trial evaluating the maintenance dose of warfarin in Chinese patients with atrial fibrillatio…
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride submitted by Chartwell RX, LLC. This marks an approval of a supplement …
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., approving a change under …
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation. [Phase 4]
Phase 4 clinical trial evaluating whether fish oil supplementation reduces the frequency and duration of atrial fibrillation episodes in pat…
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications
A completed clinical trial investigating new causes and predictors for the development of atrial fibrillation and its complications.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias
Termination of a multicenter data registry sponsored by Virginia Commonwealth University that studied outcomes after surgical treatment of a…
-
FDA label_change · 2013-05-21FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental label change for Lanoxin (digoxin) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2013-05-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited, enabling its generic use.
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) [NA]
This clinical trial update describes a multicenter study evaluating the timing of dosing for a combined ARB and calcium channel blocker regi…
-
FDA approval · 2013-05-16FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients [NA]
Clinical trial update evaluating safety and efficacy of lean body weight-based IV heparin dosing in obese and morbidly obese patients.
-
CLINICAL_TRIALS research · 2013-05-07Clinical Trial Update: Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy [NA]
This clinical trial entry from the National Institute of Cardiology in Warsaw evaluates telemetric diagnosis of arrhythmias and the efficacy…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Coronary CT Angiography Using 320-Row Volume CT in Patients With Atrial Fibrillation
This clinical trial evaluated coronary CT angiography using a 320-row volume CT in patients with atrial fibrillation. The study status is co…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Assays for and Reversal of New Anticoagulants
Clinical trial update describing assays and reversal approaches for newer anticoagulants, with relevance to patients with atrial fibrillatio…
-
CLINICAL_TRIALS research · 2013-05-03Clinical Trial Update: Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation [NA]
A clinical trial update from Deutsches Herzzentrum München describes a repeat ablation procedure in patients with relapse of atrial fibrilla…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation [Phase 3]
Phase 3 trial update for apixaban in preventing stroke in atrial fibrillation. The ARISTOTLE trial has completed and results were posted in …
-
FDA approval · 2013-04-29FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) submitted by Baxter Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation [Phase 4]
A Phase 4 clinical trial comparing ablation to antiarrhythmic drug therapy in patients with persistent atrial fibrillation has completed.